AstraZeneca Overview

  • Status
  • Public

  • Employees
  • 83,100

Employees
  • Stock Symbol
  • AZN

Stock Symbol
  • Investments
  • 85

  • Share Price
  • $127.15

  • (As of Thursday Closing)

AstraZeneca General Information

Description

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Contact Information

Formerly Known As
Zeneca Group
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Stock Exchange
LON
Primary Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$127.15 $126.38 $107.29 - $143.75 $197B 1.55B 2.72M -$0.65

AstraZeneca Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 230,621,931 206,370,813 146,302,530 145,733,740
Revenue 41,487,000 37,417,000 26,617,000 24,384,000
EBITDA 6,991,000 5,070,000 8,001,000 5,567,000
Net Income (1,063,000) 112,000 3,196,000 1,335,000
Total Assets 100,273,000 105,363,000 66,729,000 61,377,000
Total Debt 31,099,000 30,781,000 20,380,000 18,227,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AstraZeneca Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca‘s full profile, request access.

Request a free trial

AstraZeneca Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells brand
Pharmaceuticals
Cambridge, United Kingdom
83,100 As of 2021
000
00000000 000

000000

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
000000000000000
Brentford, United Kingdom
00000 As of 0000
000000000

000000

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AstraZeneca Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlaxoSmithKline Corporation Brentford, United Kingdom 00000 000000000
00000000 Corporation Basel, Switzerland 000000 000000000000
000000 00000 Corporation Mumbai, India 0000
0000000 000000 Angel-Backed New Delhi, India 0000
00. 00000'0 000000 Corporation Hyderabad, India 00000 00000 00000000000 00000
You’re viewing 5 of 29 competitors. Get the full list »

AstraZeneca Patents

AstraZeneca Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210380706-A1 Methods for treating severe asthma in patients with nasal polyposis Pending 05-Jun-2020 00000000000
US-20210369709-A1 Egfr tkis for use in the treatment of non-small cell lung cancer Pending 27-May-2020 0000000000
US-20210355196-A1 Sars-cov-2 antibodies and methods of selecting and using the same Pending 17-May-2020 000000000
US-20210355224-A1 Methods and combinations for the treatment of cancer using immune checkpoint inhibitor antibodies Pending 12-May-2020 00000000000
US-20210330665-A1 Pharmaceutical formulations Pending 24-Apr-2020 A61K9/2054
To view AstraZeneca’s complete patent history, request access »

AstraZeneca Executive Team (85)

Name Title Board Seat Contact Info
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Katarina Ageborg Executive Vice-President, Sustainability and Chief Compliance Officer; President
Cristian Massacesi Chief Medical Officer & Oncology Chief Development Officer
Jeffrey Pott JD Executive Vice President, Human Resources & General Counsel
You’re viewing 5 of 85 executive team members. Get the full list »

AstraZeneca Board Members (24)

Name Representing Role Since
0000000 0000000 00.0 Self Board Member 000 0000
00000000 00000 AstraZeneca Chief Financial Officer & Executive Director 000 0000
0000000 0000000 Self Board Member 000 0000
00000 00000000 AstraZeneca Board Member 000 0000
0000 000000 AstraZeneca Board Member 000 0000
You’re viewing 5 of 24 board members. Get the full list »

AstraZeneca Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AstraZeneca Investments & Acquisitions (85)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 22-Apr-2022 0000 00000 Drug Discovery
0000 23-Mar-2022 00000 0000 000.00 Other Healthcare Technology Systems 00000 000
000000 000000 01-Feb-2022 00000 0000 Drug Discovery
0000000000 00 03-Jan-2022 00000 0000 Surgical Devices
VaxEquity 23-Sep-2021 Seed Round 0000 Drug Discovery 0000000 0
You’re viewing 5 of 85 investments and acquisitions. Get the full list »

AstraZeneca Subsidiaries (10)

Company Name Industry Location Founded
Acerta Pharma Drug Discovery Oss, Netherlands 2012
00 000000 Drug Discovery Coppell, TX 0000
0000000 000000 Biotechnology Tokyo, Japan 0000
0000 00000000 Biotechnology Waltham, MA 0000
00000000000 000000 Corporate Pension Sodertalje, Sweden 0000
You’re viewing 5 of 10 subsidiaries. Get the full list »

AstraZeneca Exits (21)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000 23-Dec-2019 00000 00000 00 Completed
  • 2 buyers
00000 000000 28-May-2019 00000 00000 00 Completed
  • 2 buyers
00000000 000000000 25-Apr-2018 00000 00000 00 0000 Completed
  • 10 buyers
00000 000 13-Mar-2018 00000 00000 00 00000 Completed
  • 5 buyers
Rani Therapeutics 22-Dec-2017 Later Stage VC 000.00 Completed
  • 16 buyers
You’re viewing 5 of 21 exits. Get the full list »